COGNITION THERAPEUTICS INC(CGTX)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
CGTX Stock Analysis & AI Quality Score
Data updated 2026-07-26AI stock analysis and institutional research for COGNITION THERAPEUTICS INC (CGTX), a Healthcare sector company. CGTX is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of CGTX by reported 13-F value include BIOS Capital Management, DAVENPORT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. CGTX trades on the Nasdaq exchange and files with the SEC under CIK 1455365. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CGTX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for COGNITION THERAPEUTICS INC directly from SEC EDGAR.
Net Income
Q2 2026
$-3.9M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProNet Income
+30.9% YoYOperating Income
+11.4% YoYEPS (Diluted)
+62.8% YoYTotal Assets
+60.1% YoYOp. Cash Flow
+13.6% YoYFree Cash Flow
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Net Income | $-23.5M +30.9% | $-34.0M -31.7% | $-25.8M -20.5% | $-21.4M -82.6% | $-11.7M -49.5% | $-7.8M |
| Operating Income | $-47.8M +11.4% | $-54.0M -6.4% | $-50.7M -16.5% | $-43.6M -52.3% | $-28.6M -64.3% | $-17.4M |
| EPS (Diluted) | $-0.32 +62.8% | $-0.86 +0.0% | $-0.86 +5.5% | $-0.91 +70.9% | $-3.13 +57.4% | $-7.35 |
| Total Assets | $48.4M +60.1% | $30.2M -14.0% | $35.2M -30.3% | $50.4M -14.7% | $59.1M +730.7% | $7.1M |
| Operating Cash Flow | $-24.6M +13.6% | $-28.5M -77.8% | $-16.0M +13.6% | $-18.5M -410.4% | $-3.6M -5.8% | $-3.4M |
| Free Cash Flow | — | $-28.5M -76.2% | $-16.2M +13.6% | $-18.7M -411.3% | $-3.7M -6.2% | $-3.4M |
Get alerted when CGTX's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for COGNITION THERAPEUTICS INC including:
Top Institutional Holders of CGTX
BIOS Capital Management, LP
$6.9M6,000,000 shDAVENPORT & Co LLC
$4.9M4,259,511 shVANGUARD CAPITAL MANAGEMENT LLC
$4.0M3,438,775 shBlackRock, Inc.
$1.5M1,261,993 shChescapmanager LLC
$1.1M997,029 shGEODE CAPITAL MANAGEMENT, LLC
$1.0M910,006 shRENAISSANCE TECHNOLOGIES LLC
$797.3K693,288 shHilton Capital Management, LLC
$631.3K548,950 shVANGUARD FIDUCIARY TRUST CO
$584.5K508,220 shCM Management, LLC
$517.5K450,000 sh
| Fund | Value | Shares |
|---|---|---|
| BIOS Capital Management, LP | $6.9M | 6,000,000 |
| DAVENPORT & Co LLC | $4.9M | 4,259,511 |
| VANGUARD CAPITAL MANAGEMENT LLC | $4.0M | 3,438,775 |
| BlackRock, Inc. | $1.5M | 1,261,993 |
| Chescapmanager LLC | $1.1M | 997,029 |
| GEODE CAPITAL MANAGEMENT, LLC | $1.0M | 910,006 |
| RENAISSANCE TECHNOLOGIES LLC | $797.3K | 693,288 |
| Hilton Capital Management, LLC | $631.3K | 548,950 |
| VANGUARD FIDUCIARY TRUST CO | $584.5K | 508,220 |
| CM Management, LLC | $517.5K | 450,000 |
More Healthcare Companies
View all Healthcare →Put CGTX on your watchlist
Track score changes the day COGNITION THERAPEUTICS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is CGTX a good stock to buy?
13F Pro's AI-powered analysis of COGNITION THERAPEUTICS INC (CGTX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CGTX are available on the CGTX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CGTX is classified as a small company.
Which hedge funds own CGTX?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CGTX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of COGNITION THERAPEUTICS INC's investment landscape.